All Comments by Charles Glabe

  1. Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis.
  2. Structural differences in Abeta amyloid protofibrils and fibrils mapped by hydrogen exchange--mass spectrometry with on-line proteolytic fragmentation.
  3. Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP.
  4. Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease.
  5. Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides.
  6. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
  7. Biotin-avidin interaction-based screening assay for Alzheimer's beta-peptide oligomer inhibitors.
  8. Olfaction in neurodegenerative disorder.
  9. SfN: Amyloid Oligomers—Not So Elusive, After All? Part 2
  10. <i>Drosophila</i> APP Signals Synapse Formation
  11. Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.
  12. Conformation Rules Part 2: News, Common Threads, Debate from San Diego Protein Misfolding Conference
  13. A Potential Prion Therapy Focuses Attention on Protein Conversion
  14. Antibodies Found That Specifically Target Infectious Prions